Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study Of Developing Murine Primary Xenografts From Biopsies Of Liver Metastases In Patients With Advanced Pancreatic Cancer

NCT01774643 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01774643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01774643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study Of Developing Murine Primary Xenografts From Biopsies Of Liver Metastases In Patients With Advanced Pancreatic Cancer
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
November 30, 2022
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood samples, liver metastases, pancreatic cancer, tumor tissue biopsy